Cargando…
Combined Effects of Doxorubicin and Temozolomide in Cultured Glioblastoma Cells
The oncological field benefits of extensive medical research and various types of cancer notice improvements, however glioblastoma multiforme remains one of the deadliest cancers in humans with virtually no advance in survival and clinical outcome. Temozolomide, the FDA approved drug for glioblastom...
Autores principales: | BALOI, CARINA, OPRITA, ALEXANDRU, SEMENESCU, LILIANA ELEONORA, TACHE, DANIELA ELISE, POPESCU, OANA STEFANA, STAICU, GEORGIANA ADELINE, DRICU, ANICA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical University Publishing House Craiova
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940925/ https://www.ncbi.nlm.nih.gov/pubmed/36815076 http://dx.doi.org/10.12865/CHSJ.48.03.03 |
Ejemplares similares
-
The Effect of Β-Arrestin2 Overexpression Regarding Viability and Temozolomide Treatment in High-Grade Glioma Cells
por: OPRITA, ALEXANDRU, et al.
Publicado: (2022) -
The effect of Azo-dyes on glioblastoma cells in vitro
por: Sevastre, Ani-Simona, et al.
Publicado: (2023) -
Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches
por: Alexandru, Oana, et al.
Publicado: (2020) -
Updated Insights on EGFR Signaling Pathways in Glioma
por: Oprita, Alexandru, et al.
Publicado: (2021) -
Glioblastoma Stem Cells—Useful Tools in the Battle against Cancer
por: Rodriguez, Silvia Mara Baez, et al.
Publicado: (2022)